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Abstract 
Objective: In achalasia, absent peristalsis and reduced esophagogastric junction (EGJ) relaxation 
and compliance underlie dysphagia symptoms. Novel high-resolution impedance manometry 
(HRIM) variables, i.e. bolus presence time (BPT) and trans-EGJ-bolus flow time (BFT) have 
been developed to estimate the duration of EGJ opening and trans-EGJ bolus flow. The aim of 
this study was to evaluate esophageal motor function and bolus flow in children diagnosed with 
achalasia using these variables. 
Methods: HRIM recordings from 20 children who fulfilled the Chicago Classification (V3) 
criteria for achalasia were compared with recordings of 15 children with normal esophageal HRM 
findings and no other evidence suggestive of achalasia. Matlab-based analysis software was used 
to calculate BPT and BFT. 
Results: Both BPT and BFT were significantly reduced in achalasia patients compared to 
children with normal esophageal motility (BPT 3.3s vs 5.1s p<0.01; BFT 1.4s vs 4.3s p<0.001). 
BFT was significantly lower than BPT (achalasia difference 1.9s±1.3s, p=0.001 and normal 
difference 0.9±0.3s, p=0.001). Overall, there was a significant correlation between BPT and BFT 
(r=0.825, p<0.001). We observed a two-way differentiation of achalasia patients; those in whom 
the BPT and BFT were proportional, but significantly lower than in patients with normal 
peristalsis, and those in whom BFT was disproportionately lower than BPT. 
Conclusions: Calculation of BPT and BFT may help determine whether esophageal bolus 
transport to the EGJ and/or  esophageal emptying through the EGJ are aberrant. For achalasia this 
may detect flow resistance at the EGJ, potentially improving both diagnosis and objective 
assessment of therapeutic effects. 
Key words: High-Resolution Impedance Manometry – Pressure-Flow Analysis – Chicago 
Classification  
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What is known: 
 The diagnosis of achalasia is based on the combination of clinical history, 
radiography and high-resolution esophageal manometry (HRM).  
 By integrating impedance to HRM (HRIM), a new approach has been developed 
to estimate the duration of bolus presence time (BPT) and trans-EGJ bolus flow 
time (BFT). 
 In adults, BPT and BFT have shown to be discriminative in equivocal achalasia 
cases. 
 
What is new: 
 In this pediatric study, BPT and BFT were significantly reduced in achalasia 
patients compared to children with normal esophageal motility.  
 Integrated pressure-flow analysis may aid in pediatric achalasia management, 
particularly given the frequent discordance between symptoms and esophageal 
function testing.  
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Achalasia is an uncommon esophageal motility disorder, with an estimated annual 
incidence of 0.01-0.11 per 100.000 children.1 2 It is characterized by failure of relaxation  
of the lower esophageal sphincter (LES) and absence of peristalsis in the distal esophagus 
both of which lead to slow or absent bolus transit which results in symptoms of 
dysphagia, obstruction, chest pain, regurgitation, respiratory symptoms (chronic and 
nocturnal cough, aspiration) and weight loss.2-4  
In children and adults, the diagnosis of achalasia is based on the combination of the 
clinical picture, radiographic findings and the results of high-resolution esophageal 
manometry (HRM). The latter is currently considered the gold standard for diagnosing 
and subtyping achalasia.5 According to the recently published Chicago Classification 
(CC; version 3.0), three subtypes are defined, all requiring a mean integrated relaxation 
pressure (IRP4s) > 15mmHg.(4) This heavy reliance is potentially problematic. The 
IRP4s is a complex metric, not only depending on the adequacy of lower esophageal 
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sphincter relaxation, crural diaphragm contraction and EGJ opening, but also on the 
pattern and timing of distal esophageal contractility. In clinical practice, instances of 
clinically evident achalasia with IRP4s < 15mmHg do exist, especially in type I achalasia 
patients with low intraesophageal pressures and type II achalasia patients with short 
periods of panesophageal pressurizations.4 6  
ITo overcome these limitations a new approach has been developed utilizing combined 
pressure and impedance to estimate the duration of trans-EGJ-flow.10-12 In adult achalasia 
patients, trans-EGJ-bolus flow time (BFT) was significantly reduced in all achalasia 
subtypes and correlated with dysphagia severity.11 We hypothesized that the BFT could 
also be applied to better diagnose pediatric achalasia, by detecting impaired bolus flow 
and thereby complementing the IRP4s to discriminate in equivocal cases. Therefore, the 
aim of this study was to apply novel pressure impedance parameters to a cohort of 
children diagnosed with achalasia according to the CC V3.0, and to compare them with 
children referred for diagnostic HRIM, but with normal esophageal motility and no other 
evidence of achalasia.4  
 
Methods 
Combined HRIM recordings of 20 consecutive pediatric achalasia patients (clinical 
diagnosis and fulfilling CC V3.0 criteria on HRM) and 15 patients who fulfilled criteria 
for normal esophageal motility and had no signs of achalasia during endoscopy and/or 
timed barium swallow, were extracted from a clinical database at the Boston Children’s 
Hospital (Boston, MA, USA). Studies were performed between September 2010 and June 
2016. Studies were only selected if patients were <21 years at time of HRIM 
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investigation; we did not apply a lower age-limit. All included patients underwent clinical 
diagnostic HRIM to investigate dysphagia and/or gastroesophageal reflux related 
symptoms. All patients with achalasia had a non-equivocal diagnosis based on clinical 
symptoms, radiographic and manometric values. Some achalasia patients were studied 
after initial therapy (i.e. pneumatic dilation, []thoracoscopic Heller myotomy) because of 
persistent symptoms. The CC was used to diagnose and classify the subtypes of achalasia 
patients. Clinical data, including predominant symptom sub-type and medication use 
were extracted by chart review and are reported for all patients. The study was approved 
the by the Boston Children’s Hospital Institutional Review Board. 
High-resolution impedance manometry recording 
All subjects fasted for at least 8 hours for solids, and 4 hours for liquids prior to the study 
and were studied off esophageal motility influencing drugs. Depending on patient’ s age 
and height, a 3.2 or 4.2-mm diameter solid state HRIM catheter was used incorporating 
respectively 36 1-cm-spaced pressure sensors and 18 adjoining 2 cm impedance segments 
(Given Imaging, Los Angeles, CA). Patients were studied sitting in the supine or semi-
supine position with a standard protocol including 10 swallows of 5 ml saline 
administered via a syringe at ≥30 s intervals. Studies were considered for inclusion if 
they met the following criteria: (i) ≥10 saline liquid swallows performed, (ii) adequate 
catheter position to measure EGJ pressures, and (iii) no technical errors, e.g., pressure or 
impedance channel failure. Individual swallows were excluded from analysis if bolus 
passage into the proximal esophagus was not clearly discernible on the impedance 
recording, or if secondary swallows overlapped and inhibited the propagating pressure 
wave. 
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Data analysis 
Objective swallow data were evaluated by using purposed designed software 
(AIMplot copyright T Omari; MATLAB v5.0 2015, MathWorks Inc, Natick, 
Massachusetts) and by pressure topography analysis using the Chicago Classifcation 
(V3.0) using ManoView 3.0 analysis software. All studies were blindly reviewed. To 
perform pressure-flow analysis (PFA), raw pressure-impedance data for all swallows 
were visualized over a 30-second window and exported from the recording system in text 
(.txt) format. The calculations used to derive PFA metrics have been previously 
described.13 14 In brief, pressure impedance recordings are displayed as pressure 
topography plots with embedded impedance recordings which show bolus flow 
movements and relaxation and movement of the upper and lower esophageal sphincter 
pressure zones. On selection of specific landmarks on the pressure topography space-time 
plot, specific spatial and temporal regions of interest are mapped.  Data for three 
pressure-flow variables are presented, these are Peak Pressure, defined as the pressure at 
maximum contraction, Intra-Bolus Distension Pressure defined as the pressure at nadir 
impedance, and the Impedance Ratio, defined by the ratio of nadir impedance to peak 
pressure impedance.  13 As the algorithm used to derive these variables requires 
identification of an esophageal pressure peak, they could not be derived for those patients 
with achalasia Type I. As only one patient had achalasia Type III, only the grouped data 
for those patients with achalasia Type II (both treated and untreated) and patients with 
normal esophageal motility are shown. Unless otherwise indicated, these variables are 
displayed as mean values for the distal esophagus from transition zone to EGJ. In cases 
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where the transition zone was not visible, the distal two-thirds of the esophageal tracing 
was used. 
Using the impedance signals, first, potential regions of bolus presence within the EGJ 
were defined as the intervals during which there was an impedance drop >50% when 
compared to baseline, as previously described.10 The duration of bolus presence within 
the EGJ (BPT) was determined, with the onset of bolus presence defined as the point at 
which the impedance dropped 90% relative to baseline impedance and the offset as the 
return to 50%. The trans-EGJ-bolus flow time (BFT) was calculated by summing all 
periods fulfilling the criteria of BPT, and subtracting time periods of crural contraction.10 
11 The difference between BFT and BPT was additionally calculated. As previously 
described, we used the ratio of BFT and BPT (BFT/BPT) to define the effectiveness of 
trans-EGJ emptying relative to the period of bolus presence (i.e. ratio of 1 means 
unrestricted trans-EGJ flow, ratio of 0.5 means that flow was estimated to occur during 
only half the time that bolus was present).10 11 The 10th percentile of BFT and BPT in 
patients with normal esophageal HRM findings were used to define ranges of normality.  
Statistical analysis 
Distribution of data was evaluated using the Kolmogorov-Smirnov test. Parametric data 
are expressed as mean ± standard deviation (SD), and nonparametric data as median, 
interquartile range (IQR). Mann-Whitney U or t-tests and anova or Kruskal–Wallis tests 
were used to compare mean or median values of continuous outcomes respectively 
between patients with normal motility and achalasia patients and across achalasia 
subtypes. Tukey's adjustment for multiple pairwise comparisons was employed to 
examine pairwise differences (e.g., across patient groups and across achalasia subtypes). 
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Bivariate associations between continuous variables were evaluated via Pearson's sample 
correlation coefficients and/or Spearman's sample correlation coefficients in cases of 
possible violation of relevant statistical assumptions. Statistical tests were performed 
using IBM SPSS Statistics 23 (SPSS Inc, Chicago, Illinois). Differences were considered 




Patient characteristics are displayed in Supplemental Digital Content, Table 1, 
http://links.lww.com/MPG/B17. Fifteen patients were diagnosed with type II achalasia, 
five with type I and two with type III. Seven of the achalasia patients were studied post-
intervention (i.e. balloon dilatation and/or thoracoscopic Heller myotomy), of whom two 
patients (both type II achalasia) had also been studied prior to treatment. As these patients 
were included in both the pre- and post-intervention groups, a total number of 22 HRIM 
tracings was analyzed. All patients that were studied post-intervention, were studied due 
to persisting dysphagia symptoms. Of these 7 patients, two were type I, four were type II 
and one was type III. In one patient, prior fundoplication was undone prior to myotomy.   
Comparison of EGJ parameters 
Comparisons of parameters measured at the EGJ between the three patient groups and 
amongst achalasia subtypes are presented in Table 1. Integrated relaxation pressure 
(IRP4s) was significantly lower in the patients with normal motility and treated achalasia 
patients compared to the untreated achalasia patients (adjusted p < 0.001 and p = 0.014), 
but did not differ between treated achalasia patients and patients with normal motility 
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(Figure 1; adjusted p = 0.892). Patients with normal motility had significantly higher BFT 
(adjusted p < 0.001 and p = 0.020 respectively) and BPT (adjusted p = 0.001 and p = 
0.020) when compared to the untreated and treated achalasia patients. There was no 
difference in BFT and BPT between treated and untreated achalasia patients (adjusted p = 
0.662 and p = 1.000 respectively). None of the three EGJ parameters was found to 
correlate significantly with patients’ age, height or weight (overall and subgroup 
analysis).  
Comparisons of PFA characteristics (Normal motility and achalasia type II only) 
Comparisons of PFA characteristics between patients with achalasia Type II and patients 
with normal motility are presented in Table 2. There were no significant differences in in 
distension pressures or impedance ratio between the untreated and treated achalasia Type 
II patients. When compared to patients with normal motility, we found lower peak 
pressures (adjusted p = 0.001 and p = 0.032 respectively), and higher distension pressures 
(adjusted p < 0.001 and p = 0.020 respectively) in patients with untreated and treated 
achalasia. The impedance ratio  was higher in patients with untreated achalasia (adjusted 
p < 0.001) suggesting greater bolus residual..  
Concordance between IRP4s, BFT and BPT 
Overall, there was a significant correlation between IRP4s and BFT, IRP4s and BPT and 
between BFT and BPT (Figure 1; Spearman’s r = -0.638, p < 0.001; r = -0.358, p = 0.030 
and r = 0.825, p < 0.001).  There was a significant correlation between BPT and BFT for 
children with normal motility (Spearman’s r = 0.961, p < 0.001) and for treated achalasia 
patients (Spearman’s r = 0.811, p = 0.027). Only a weak trend was noted for untreated 
achalasia patients (r = 0.468, p = 0.078). 
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As shown in Figure 1, patients with normal motility showed a linear relationship between 
BPT and BFT and had a BFT/BPT ratio ≥ 0.5, estimating trans-EGJ-flow to occur during 
at least half the time that the bolus was present. In contrast, achalasia patients appeared to 
separate into two groups; 1. those in whom the BPT and BFT were proportional, but 
significantly lower than patients with normal peristalsis (i.e. BFT/BPT ratio ≥ 0.5 and 
BPT OR BPT < 10th percentile of patients with normal motility), and 2. those in whom 
BFT was disproportionately lower than BPT (BFT/BPT ratio < 0.5). Patients in Group 2 
appeared to have evidence of greater distal flow resistance as indicated by a significantly 
higher IRP4s and higher PFI compared to patients in Group 1 (p = 0.028 and p < 0.001 
respectively). Untreated Type 2 achalasia patients were more often in Group 2 (64%) 
compared to Group 1 (36%) however this was not a statistically significant proportion 
(Fisher exact test statistic 0.395). One of the treated achalasia Type II patients that 
underwent HRIM study twice due to persisting dysphagia symptoms was initially in 
Group 2 and shifted to Group 1 at repeat analysis post-intervention, suggesting that 
therapy had been ineffective, even though the IRP4s had normalized (40.2mmHg to 
6.6mmHg). The other treated patient, that was first in Group 1, showed similar BFT and 
BPT characteristics at repeat analysis post-intervention as patients with normal motility, 
although dysphagia symptoms persisted in this patient.  
Esophageal emptying, pressurization and trans EGJ-flow 
Overall, there was a significant negative correlation between impedance ratio and BPT 
and BFT (Spearman’s r = -0.603, p < 0.001 and r = -0.760, p < 0.001 respectively). There 
was also a significant overall negative correlation between distension pressure and BPT / 
BFT (r = -0.326 / -6.616, p = 0.049 / <0.001). Patients in Group 2 had significantly higher 
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distension pressures when compared to patients with normal peristalsis (20.2 (17.2 – 
23.4) mmHg vs 7.4 (4.6 – 11.1) mmHg; adjusted p < 0.001). There were no significant 
differences in between patients in Group 1 (11. 6 (7.9 – 17.1) mmHg) and patients in 
Group 2 (p = 0.105) or patients with normal motility (p = 0.083 and p = 0.128 
respectively). The impedance ratio was significantly lower in patients with normal 
motility (0.29 (0.19 – 0.39)) when compared to patients in Group 1 (0.79 (0.45 – 0.90); p 
= 0.001) and Group 2 (0.80 (0.62 – 0.87); p < 0.001)), but did not differ significantly 
between Groups 1 and 2 (p = 1.000) 
 
Discussion 
The aim of this study was to evaluate esophageal motor function in children diagnosed 
with achalasia using novel esophageal pressure-flow variables. Our findings support that 
in children, some metrics measured at the EGJ, BFT in particular, provide added 
information on EGJ outflow obstruction, as was previously shown in adults.10 11 BFT 
integrates measures of EGJ opening (impedance) and pressure to predict when trans-EGJ 
bolus flow is occurring, thereby providing a more comprehensive evaluation of EGJ 
function than the (pressure only) IRP4s.  
In our cohort, both BFT and BPT were significantly lower in achalasia patients compared 
to patients with normal esophageal motility. Consistent with the known effect of dilation 
therapy, the IRP4s was significantly lower in patients post-intervention (Figure 1).15 
However, unlike IRP4s, BFT and BPT were not significantly different in the treated 
group when compared to the untreated group. This is consistent with the fact that the 
treated achalasia patients were presenting with persistent symptoms. While this suggests 
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that the BFT may actually correspond with the clinical impact of therapy, our study did 
not include patients who responded to therapy and therefore cannot fully address this 
question. A recent study prospectively followed a cohort of 75 achalasia patients after 
pneumotic dilatation or Heller myotomy and found that BFT correlated better with 
clinical and radiographic treatment outcome as compared to IRP4s.16  
The CC and its metrics have been developed to characterize specific features of 
deglutitive esophageal function and classify motility disorders in a hierarchical fashion, 
based upon data from healthy adults.4 Because of the lack of established age-appropriate 
reference ranges for the metrics which drive the CC, corroboratory evidence in support of 
a CC diagnosis is particularly important in children. In a previous study, we found 
younger age to correlate significantly with higher IRP4s, potentially leading to the over-
diagnosis of achalasia and other IRP4s driven CC diagnoses, when a fixed cut-off values 
are applied. Parameters such as the impedance ratio, and the esophageal impedance 
integral ratio (not investigated here), may have additive value by defining the degree and 
extent of bolus retention over multiple swallows.17 In addition, distension pressures were 
higher amongst achalasia patients and were negatively correlated with BFT, consistent 
with  flow resistance during esophageal emptying 15 
Overall, we found significant correlation between BFT and BPT and observed a two-way 
differentiation of achalasia patients; those in whom the BPT and BFT were proportional, 
but significantly lower than in patients with normal peristalsis (Group 1), and those in 
whom BFT was disproportionately lower than BPT (Group 2). Patients in both Group 1 
and 2 showed significantly higher impedance ratio when compared to patients with 
normal motility and patients in Group 2 also showed significantly higher distension 
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pressures. These data suggest, conceptually, that the BFT to BPT relationship may help 
stratify patients with a disproportionately reduced BFT as a marker of outflow resistance 
and patients with the ability to generate sufficient intra-esophageal pressure to establish a 
flow-permissive gradient across the EGJ. However, further studies are needed to explore 
the effect of therapy on individual patients characterized in this way.    
To our knowledge, no other study has specifically investigated pressure-impedance 
characteristics in a cohort of pediatric achalasia patients. This work has limitations as it 
requires both HRIM recordings and MATLAB programming thereby making it not 
widely available. The analysis technique still requires identification of appropriate 
landmarks and will be subject to the expertise of the interpreter in localizing these 
landmarks. However, its automation and objectivity in the derivation of additional 
functional measures of bolus movement in relation to esophageal and EGJ pressurization 
may complement a pressure-only derived diagnosis of achalasia and its subtypes. We 
recognize the limitations of a retrospective cohort study with sometimes incomplete 
clinical data, particularly in relation to symptom severity. As age of included patients 
ranged from 8-21 years old at time of HRIM investigation, it is not sure whether results 
could be extrapolated to a younger achalasia population. Further, our patients with 
normal motility are not equivalent to healthy controls, the achalasia cohort was 
heterogeneous and specific pediatric validation studies of the parameters used to 
characterize EGJ outflow resistance have not been performed. Additionally, our cohort 
only included two patients that were studied both pre- and post-intervention due to 
persisting symptoms. As a result, we were unable to evaluate parameters in relation to 
treatment success. 
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In summary, in pediatric achalasia patients, novel integrated pressure-flow variables may 
have additional value for diagnostic assessment and monitoring of therapeutic efficacy. 
Of the variables assessed in this study, the BFT parameter and its relationship with bolus 
presence within the EGJ may have clinical value by stratifying patients with a 
disproportionately reduced BFT as a marker of outflow resistance.  Our study suggests 
that an improved HRIM evaluation using integrated pressure-flow criteria would better 
aid in pediatric achalasia management decisions, particularly given the frequent 
discordance between symptomatic and objective measures of esophageal function. 
However, further studies are needed to correlate these parameters with symptom severity 
before and after therapy.  
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Figure 1: EGJ parameters in achalasia patients (all subtypes) and patients with normal 
motility. In symptomatic treated achalasia patients, IRP4s normalized to the level seen in 
patients with normal motility, reflecting the effect of dilation therapy on the LES. BFT 
and BPT were significantly reduced in both symptomatic treated and untreated achalasia 
patients when compared to patients with normal motility, but not between treated and 
untreated achalasia patients. This may potentially reflect that the treated achalasia 
patients were presenting with refractory symptoms, suggesting that BFT and BPT may 
actually correspond with the clinical impact of therapy,  
a,b,cindicates pairwise significance between Groups using Tukey's adjustment for multiple 
pairwise comparisons.  
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Figure 2:  Concordance of trans-EGJ-bolus flow time (BFT) and bolus presence time 
(BPT) amongst patients with normal esophageal motility and achalasia subtypes pre- and 
post-intervention. The dots indicate patients naïve to treatment, the squares indicate 
treated achalasia patients. Colors represent the different achalasia subtypes. * and # 
represent the same patient before (circle) and after (square) intervention.  Circles 
demarcate separation of achalasia patient into two groups: Group 1 (undashed circle) - 
reduced esophagogastric junction (EGJ) outflow proportionate to transport (BFT/BPT 
ratio ≥ 0.5 and BPT OR BPT < 10th percentile of patients with normal motility) and 
Group 2 (dashed circle) - reduced EGJ outflow disproportionate to transport (BFT/BPT 
ratio < 0.5). 
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Table 1 – Comparison of EGJ Parameters 
Group  BFT (s) BPT (s) BPT and BFT 
difference (s) 
BFT and BPT ratio (s) IRP4s (mmHg) 
Untreated Achalasia (n=15) 
Type 1 (n=3)* 
Type 2 (n=11) 
Type 3 (n=1)# 
All  
 
2.4 (0.9 – 2.4) 
1.3 (0.6 – 1.8) 
2.9 
1.4 (0.6 – 1.9)aaa 
 
2.9 (2.4 – 3.0) 
3.5 (1.7 – 4.1) 
7.2 
3.3 (2.4 – 4.1)aa 
 
0.56 (0.55 – 1.52) 
2.3 (0.9 – 2.9) 
4.3 
1.9 (0.6 – 2.9) 
 
0.8 (0.4 – 0.8)  
0.4 (0.3 – 0.5)  
0.4 
0.4 (0.3 – 0.6)aaa 
 
 
43.9  (21.1 – 51.3) 
43.2 (33.8 – 51.0) 
48.1 
43.9 (33.8 – 51.0)aaa,c 
 
Treated Achalasia (n=7) 
Type 1 (n=2)* 
Type 2 (n=4) 




1.9 (1.3 – 2.6)  
2.3 (1.3 – 3.4) 
2.1 
2.1 (1.3 – 2.6)a 
 
 
2.5 (1.7 – 3.3) 
4.6 (2.4 – 5.4) 
2.6 
3.3 (1.7 – 4.7)a 
 
 
0.6 (0.4 – 0.7) 
1.8 (0.7 – 3.0) 
0.57 
0.7 (0.6 – 2.6) 
 
 
0.8 (0.8 – 0.8) 
0.5 (0.4 – 0.7) 
0.8 
0.8 (0.5 – 0.8) 
 
 
6.2 (5.4 – 6.9) 
11.9 (7.2 – 38.2) 
3.1  
6.9 (5.4 – 15.1)b 
 
Normal (n=15)  
 
4.3 (3.8 – 5.5)bbb, c 
 
5.1 (4.6 – 6.3)bb,c 
 
0.9 (0.6 – 1.2) 
 
0.8 (0.8 – 0.9)bbb 
 
5.8 (2.2 – 11.6)bbb 
 











*Range provided; #Only one patient with type III achalasia. 
a,b,c Indicates pairwise significance between Groups using Tukey's adjustment for multiple pairwise comparisons. 
avs.Normal, bvs.Untreated Achalasia, cvs. Treated Achalasia (a,b,cp<0.05, aa,bb,ccp<0.01, aaa,bbb,cccp<0.001). 
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Table 2 – Comparison of PFA Parameters; Type 2 Achalasia vs. Normal Only 






Untreated Achalasia Type II (n=11) 
 
34.9 
(29.8 – 54.8)aa 
20.7 
(16.1 – 27.3)aaa 
0.8 
(0.8 – 0.9)aaa 




(27.6 – 59.6)a 
18.2 
(25.4 – 16.9)a 
0.6 




(53.6 – 101.0)bb,c 
7.4 
(4.6 – 11.1)bbb,c 
0.3 
(0.2 – 0.4)bbb 
p-value (ANOVA, All Groups) 0.001 < 0.001 < 0.001 
a,b,cindicates pairwise significance between Groups using Tukey's adjustment for multiple pairwise comparisons.  
avs.Normal, bvs.Untreated Achalasia type II, cvs. Treated Achalasia type II (a,b,cp<0.05, aa,bb,ccp<0.01, aaa,bbb,cccp<0.001 
